Loading…
Alkermes plc is projected to rise to $66.53 by 2027, a +33% move from its current price of $50.03. ALKS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $49.00 | $50.06 | $51.14 | +0.05% |
| Aug 2 | $48.59 | $50.08 | $51.62 | +0.10% |
| Aug 3 | $48.29 | $50.11 | $51.99 | +0.16% |
| Aug 4 | $48.04 | $50.13 | $52.32 | +0.21% |
| Aug 5 | $47.82 | $50.16 | $52.61 | +0.26% |
| Aug 6 | $47.63 | $50.19 | $52.88 | +0.31% |
| Aug 7 | $47.46 | $50.21 | $53.13 | +0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $47.46 | $50.21 | $53.13 | +0.37% |
| Week 2 | $46.53 | $50.40 | $54.59 | +0.73% |
| Week 3 | $45.87 | $50.58 | $55.78 | +1.10% |
| Week 4 | $45.35 | $50.77 | $56.84 | +1.47% |
| Week 5 | $44.91 | $50.95 | $57.81 | +1.85% |
| Week 6 | $44.54 | $51.14 | $58.72 | +2.22% |
| Week 7 | $44.21 | $51.33 | $59.60 | +2.60% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients.
It also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Alkermes plc trades at $48.34 per share and has a market cap of $8.11B. It ranks 1041 by market cap, reflecting its position as a mid-sized biopharmaceutical company with a focused portfolio.
The price outlook in the supplied forecast shows upside potential, with the average price moving from $48.34 in 2026 to $124.20 in 2030, and up to $980.99 by 2050.
Projected returns also rise across the forecast, with ROI expanding from 0% in 2026 to 156.9% by 2030 and 1929.4% by 2050, signaling meaningful long-term upside alongside notable uncertainty in the near term.
A major floor 44.6% below — a decisive break under it would weaken the trend.
The nearest floor, 11.0% below — buyers have tended to step in here.
The nearest ceiling, 10.4% above — a clean break opens room to run.
A major ceiling 21.2% above — clearing it would confirm fresh momentum.
Key ALKS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALKS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $50.90 | Sell | $50.52 | Sell |
| MA 10 | $51.73 | Sell | $51.24 | Sell |
| MA 20 | $52.48 | Sell | $51.21 | Sell |
| MA 50 | $47.49 | Buy | $47.72 | Buy |
| MA 100 | $40.12 | Buy | $42.84 | Buy |
| MA 200 | $35.42 | Buy | $38.02 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.84 | Neutral |
| Stoch RSI (14) | 32.57 | Neutral |
| CCI (20) | -131.57 | Sell |
| Williams %R (14) | -63.50 | Info |
| MACD (12,26,9) | -0.79 | Sell |
| ROC (12) | -3.04 | Sell |
| Bollinger %B (20,2) | 0.13 | Neutral |
| Stochastic %K (14) | 36.50 | Neutral |
| TRIX (15) | 0.44 | Buy |
| Awesome (5,34) | 0.14 | Buy |
| Ultimate (7,14,28) | 37.06 | Neutral |
| Momentum (10) | -1.91 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 49.34 | Buy |
| ADX (14) | 27.05 | Sell |
| ATR (14) | 0.98 | Info |
Technical sentiment is BULLISH, with RSI14 at 40. The stock trades above its SMA50 of $47.23 and well above its SMA200 of $35.32.
The 30-day range runs from $42.13 to $55.46, with a current price of $48.34. A nearby support sits at $44.09 and resistance at $55.22, and annualized volatility is 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $27.20 | $50.03 | $68.74 | 0% | Neutral | |
| $54.11 | $66.53 | $85.79 | +33% | Bullish | |
| $62.47 | $78.48 | $104.32 | +57% | Bullish | |
| $77.77 | $99.44 | $135.36 | +99% | Bullish | |
| $98.38 | $127.77 | $177.42 | +155% | Bullish | |
| $117.68 | $154.99 | $219.03 | +210% | Bullish | |
| $128.47 | $171.42 | $246.09 | +243% | Bullish | |
| $141.16 | $190.66 | $277.64 | +281% | Bullish | |
| $157.35 | $214.98 | $317.21 | +330% | Bullish | |
| $170.67 | $235.74 | $352.14 | +371% | Bullish | |
| $292.27 | $424.00 | $666.92 | +747% | Bullish | |
| $632.11 | $995.60 | $1,689.88 | +18.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $27.20 | $50.03 | $58.27 | +0.00% |
| August 2026 | $43.20 | $50.47 | $60.16 | +0.87% |
| September 2026 | $44.63 | $52.47 | $63.22 | +3.98% |
| October 2026 | $45.39 | $53.65 | $65.17 | +2.24% |
| November 2026 | $45.44 | $53.94 | $65.97 | +0.53% |
| December 2026 | $46.88 | $55.86 | $68.74 | +3.57% |
Click any year to see its month-by-month ALKS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ALKS to range from $27.20 to $68.74 through 2026. The $50.03 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ALKS price prediction for 2027 points to an average of $66.53 (low $54.11, high $85.79) — a potential gain of +33% on today's $50.03. Buyers look set to stay in control over this stretch.
In 2028, ALKS is projected to trade between $62.47 and $104.32, averaging $78.48 — a potential gain of +57% from today's $50.03. That is up +18% on the projected 2027 average. Momentum favours further upside here.
Alkermes plc's 2029 outlook centres on $99.44, within a $77.77 to $135.36 range. That is up +27% on the projected 2028 average. That marks a +99% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ALKS could reach as high as $177.42, with a base case around $127.77 and support toward $98.38 — roughly +155% from $50.03. Momentum favours further upside here.
Expect ALKS to range from $117.68 to $219.03 through 2031. The $154.99 average target implies a +210% move from current prices. That is up +21% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ALKS price prediction for 2032 points to an average of $171.42 (low $128.47, high $246.09) — a potential gain of +243% on today's $50.03. Momentum favours further upside here.
In 2033, ALKS is projected to trade between $141.16 and $277.64, averaging $190.66 — a potential gain of +281% from today's $50.03. That is up +11% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Alkermes plc's 2034 outlook centres on $214.98, within a $157.35 to $317.21 range. That is up +13% on the projected 2033 average. That marks a +330% change versus current levels. Momentum favours further upside here.
By 2035, ALKS could reach as high as $352.14, with a base case around $235.74 and support toward $170.67 — roughly +371% from $50.03. Buyers look set to stay in control over this stretch.
Expect ALKS to range from $292.27 to $666.92 through 2040. The $424.00 average target implies a +747% move from current prices. That is up +80% on the projected 2035 average. Momentum favours further upside here.
The ALKS price prediction for 2050 points to an average of $995.60 (low $632.11, high $1,689.88) — a potential gain of +18.9x on today's $50.03. Buyers look set to stay in control over this stretch.
Investing $1,000 in ALKS today (≈ 19.988007 ALKS) could be worth
$19,900.01
+$18,900.01 (+1890%) by 2050 · US Dollar
Based on the average projected ALKS price of $995.6 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALKSwould be worth at today's price.
$1,000 invested in ALKS on Jul 30, 2025 (≈ 35.803795 ALKS) would be worth
$1,791.26
+$791.26 (+79.1%) today · 1.79× · US Dollar
Based on a ALKS entry price of $27.93 vs. today's $50.03.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $52.97 | $944.5 | -5.6% |
| 1 month ago | $52.4 | $954.77 | -4.5% |
| 3 months ago | $33.38 | $1,498.8 | +49.9% |
| 6 months ago | $33.89 | $1,476.25 | +47.6% |
| 1 year ago | $27.93 | $1,791.26 | +79.1% |
| All time (5.0y) ago | $26.94 | $1,857.09 | +85.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALKS forecast.
Our base-case forecast reaches $100.00 around 2030.
Implied market cap at $100.00: $16.78B
The multi-year outlook shows substantial upside, with the average price rising from $48.34 in 2026 to $124.20 in 2030, and higher in later years. The forecast captures a bullish path with the 2030 average at $124.20 and an ROI of 156.9%.
From 2031 to 2035, the forecasted averages are $151.15, $167.76, $186.63, $210.66, and $231.15 respectively, with ROIs of 212.7%, 247%, 286.1%, 335.8%, and 378.2%.
By 2040 the average price is $417.48 with ROI 763.6%, and by 2050 the average price is $980.99 with ROI 1929.4%.
These are estimates, not guarantees.
Tap a question to reveal the answer.
Average forecast price in 2030 is $124.20.
The forecast shows bullish sentiment in later years with average prices rising to $124.20 by 2030 and $980.99 by 2050, and ROI reaching 156.9% by 2030 and 1929.4% by 2050.
The 2050 max forecast is $1,653.31, and the 2050 average is $980.99; hitting $1,000 is within the forecast as the max exceeds $1,000.
The 30-day range is $42.13 to $55.46, current price is $48.34, with a nearby support at $44.09 and resistance at $55.22.
Alkermes plc Community Discussion
0Share your Alkermes plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.